Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/14/2010WO2010117425A1 Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
10/14/2010WO2010117346A2 Stable pharmaceutical compositions with high bioavailibility
10/14/2010WO2010117342A1 A plant extract comprising statins and preparation techniques and uses thereof
10/14/2010WO2010117323A1 Method and apparatus for producing heat energy and carbon dioxide
10/14/2010WO2010117296A1 Agent for preventing influenza and acute respiratory diseases
10/14/2010WO2010117274A1 Carbohydrates enhancing the production of a c5 and/or a c6 scfa
10/14/2010WO2010117241A2 Composition for prevention or treatment of hypertrophic scars or keloids
10/14/2010WO2010117233A2 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same
10/14/2010WO2010117199A2 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles
10/14/2010WO2010117194A2 Composition for preventing or treating gastric disorders containing an active component comprising a fatty acid series compound
10/14/2010WO2010117170A2 Pharmaceutical composition for treating or preventing burn injuries
10/14/2010WO2010117090A1 Novel isoquinolinyloxymethyl heteroaryl derivatives
10/14/2010WO2010117085A1 Aryl indole derivatives
10/14/2010WO2010117084A1 Novel isoquinoline derivatives
10/14/2010WO2010117077A1 Therapeutic agent for chorioretinal diseases comprising sirolimus derivative as active ingredient
10/14/2010WO2010117071A1 Ubiquitin fusion gene, and dna vaccine using same
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010117035A1 Complex and process for production thereof, and granules and tablets
10/14/2010WO2010117014A1 Triazine derivative
10/14/2010WO2010116926A1 Tumor-specific promoter and use thereof
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116866A1 Agent for ameliorating or preventing metabolic syndrome
10/14/2010WO2010116834A1 Process for production of orally ingestible composition containing arabinosyl vitexin, and use of the composition
10/14/2010WO2010116760A1 Inhibitor for elevation of gip level
10/14/2010WO2010116740A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010WO2010116673A1 Mitochondrial function-improving agent
10/14/2010WO2010116550A1 Method for testing sensitivity of tumor tissue
10/14/2010WO2010116423A1 Method for inhibiting telomerase reaction
10/14/2010WO2010116380A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
10/14/2010WO2010116342A2 Non-steroidal compounds for androgen receptor modulation
10/14/2010WO2010116337A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
10/14/2010WO2010116317A1 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
10/14/2010WO2010116302A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010WO2010116282A1 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010116267A1 High dosage doramectin formulation
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010116210A1 Acidic beverage containing low-methoxyl amidated pectin and no added calcium for a satiety effect
10/14/2010WO2010116177A1 A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010116176A1 Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010116127A1 Combination of cetirizine and mefenamic acid for the treatment of exacerbations of asthma
10/14/2010WO2010116099A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/14/2010WO2010116098A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010WO2010116090A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
10/14/2010WO2010116084A1 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
10/14/2010WO2010116078A1 Foaming pharmaceutical composition that does not contain a propellant gas
10/14/2010WO2010115993A1 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
10/14/2010WO2010115981A1 7-azadispiro [3.0.4.1] decane-8-carboxamides as hepatitis c virus inhibitors
10/14/2010WO2010115974A1 Crystal forms of saxagliptin
10/14/2010WO2010115952A1 Indane derivatives
10/14/2010WO2010115947A2 Prolonged-release alfa-lipoic acid
10/14/2010WO2010115937A1 Process for preparing pyrrolidinium salts
10/14/2010WO2010115932A1 Combination for the treatment of bone loss
10/14/2010WO2010115901A1 Pyrrolopyridine therapeutic compounds
10/14/2010WO2010115890A1 Acidic beverage containing low-methoxyl amidated pectin and no added calcium for a satiety effect
10/14/2010WO2010115886A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010WO2010115869A1 Propofol phosphonyl derivatives, synthesis, and use in long acting formulations
10/14/2010WO2010115852A1 Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115751A2 Oxadiazole derivatives
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115724A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1h-quinolin-2-one base or salts or hydrates thereof
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010WO2010115615A1 Improved glucocorticoid therapy
10/14/2010WO2010115576A1 Melting tablet containing a sildenafil salt
10/14/2010WO2010115556A1 Compounds and uses
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115475A1 Process for producing rapidly disintegrating spheroids (pellets), granules and/or mixtures thereof
10/14/2010WO2010115342A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO [4, 3-b] INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
10/14/2010WO2010115291A1 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
10/14/2010WO2010115267A1 Once-daily oral ir/cr pramipexole formulation
10/14/2010WO2010115264A1 Inhibitors of hiv replication
10/14/2010WO2010115252A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/14/2010WO2010115230A1 Immunogenic composition and uses thereof
10/14/2010WO2010115229A1 Immunogenic composition and uses thereof
10/14/2010WO2010094452A3 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
10/14/2010WO2010094090A3 Synucleinopathies
10/14/2010WO2010089772A3 Chronotherapeutic pharmaceutical composition
10/14/2010WO2010083384A9 Non-peptidyl, potent, and selective mu opioid receptor antagonists
10/14/2010WO2010082072A8 Process for the preparation of rosuvastatin salts
10/14/2010WO2010080756A3 Harmine derivatives for reducing body weight
10/14/2010WO2010080580A3 Extended-release pharmaceutical formulations
10/14/2010WO2010078517A3 Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer
10/14/2010WO2010075086A3 Pyrrolidinone inhibitors of pde-4
10/14/2010WO2010075060A3 Methods and compositions for modulating proline levels
10/14/2010WO2010071826A3 Methods for treating osteoclast-related disease, compounds and compositions thereof
10/14/2010WO2010070664A4 Curcuminoids and its metabolites for the application in ocular diseases
10/14/2010WO2010068918A3 Novel targets for treatment of hypercholesterolemia
10/14/2010WO2010068794A3 Hif inhibitors and use thereof
10/14/2010WO2010068775A3 Alkyne antagonists of lysophosphatidic acid receptors
10/14/2010WO2010068760A3 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
10/14/2010WO2010068717A3 Pyrazolinone scavengers of free radicals
10/14/2010WO2010068037A3 Anti-cancer composition containing 4-hexylresorcinol-1,3-diol as active ingredient
10/14/2010WO2010066912A4 Compounds having activity in correcting mutant cftr cellular processing
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
1 ... 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 ... 7860